C8.T
CANCELLED SEC. 8 (10-YR)
09/28/2025
Back to search
Official data from USPTO
TREANDA (BENDAMUSTINE HCI) FOR INJECTION
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
47
Latest update
09/29/2025
Trademark type
Combined
Nice classes
16
Filing date
10/10/2013
Registration date
03/03/2015
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/14/2021
Last transaction
09/29/2025
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
11/17/2014
First use in commerce
11/17/2014
Drawing code
3
Owner type
16
Owner location
WEST CHESTER, PA
Examiner
DWYER,JOHN D
Current location
Historical data usage
Mark description
The mark consists of the black word "TREANDA" and the black words "BENDAMUSTINE HCI" written in black brackets and the black words "FOR INJECTION" written outside the brackets with design of two green and purple eyebrows on the left side of the mark.
Holders and representatives
Holders
CEPHALON LLC
Cephalon, Inc.
Cephalon, Inc.
Representatives
Laurence Rickles TEVA PHARMACEUTICALS USA, INC.
Technical classification
Nice Classes
Class 16
Vienna Codes
No Vienna codes available.
Goods and services
Class 16
Pamphlets and brochures containing information regarding the treatment of cancer
Publications
History of USPTO decisions and trademark events.
47 publications found
PR89
POST REGISTRATION ACTION MAILED - SEC. 8 & 9
02/16/2025
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
02/14/2025
PR89
POST REGISTRATION ACTION MAILED - SEC. 8 & 9
06/27/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/27/2024
E89R
TEAS SECTION 8 & 9 RECEIVED
03/27/2024
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
03/03/2024
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
12/07/2022
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
09/14/2021
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
09/14/2021
A7OK
AMENDMENT UNDER SECTION 7 - PROCESSED
09/14/2021
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
09/09/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
07/14/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/14/2021
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
07/14/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/14/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/14/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
07/14/2021
PRAM
POST REGISTRATION ACTION MAILED - SEC. 7
07/13/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/13/2021
E815
TEAS SECTION 8 & 15 RECEIVED
03/03/2021
ES7R
TEAS SECTION 7 REQUEST RECEIVED
03/03/2021
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
03/03/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
03/03/2015
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
01/30/2015
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
01/29/2015
SUPC
STATEMENT OF USE PROCESSING COMPLETE
01/13/2015
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
01/12/2015
IUAF
USE AMENDMENT FILED
12/01/2014
EISU
TEAS STATEMENT OF USE RECEIVED
12/01/2014
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
07/08/2014
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/13/2014
PUBO
PUBLISHED FOR OPPOSITION
05/13/2014
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/23/2014
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
04/05/2014
ALIE
ASSIGNED TO LIE
04/05/2014
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/17/2014
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/10/2014
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/10/2014
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/10/2014
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/03/2014
GNRT
NON-FINAL ACTION E-MAILED
02/03/2014
CNRT
NON-FINAL ACTION WRITTEN
02/03/2014
DOCK
ASSIGNED TO EXAMINER
01/27/2014
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
10/19/2013
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/18/2013
NWAP
NEW APPLICATION ENTERED
10/14/2013
Continuous trademark protection
Get notified about every new filing that threatens TREANDA (BENDAMUSTINE HCI) FOR INJECTION or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.